Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

APO-DOXYCYCLINE MR DIN 02512645

Status: Marketed
Holder: APOTEX INC
Molecule: DOXYCYCLINE (DOXYCYCLINE MONOHYDRATE)
Available to quote

Health Canada record

Active ingredient(s)DOXYCYCLINE (DOXYCYCLINE MONOHYDRATE) 40 MG
Dosage formCapsule (Immediate- And Delayed-Release)
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCJ01AA02 DOXYCYCLINE
Original market date01-Sep-2021
Current status date01-Sep-2021
SourceHealth Canada DPD

Establishment licence of the holder

Apotex Inc — licence 100375, currently licensed, last inspection rating C (2026-04-21).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing DOXYCYCLINE (DOXYCYCLINE MONOHYDRATE)

DINProductCompanyFormStrengthStatus
02495538APO-DOXYCYCLINE MODIFIED RELEASEAPOTEX INCCapsule (Immediate- And Extended-ReleaseDOXYCYCLINE (DOXYCYCLINE MONOHYDRATE) 40 MGApproved
02375885APPRILONGALDERMA CANADA INC.Capsule (Immediate- And Delayed-Release)DOXYCYCLINE (DOXYCYCLINE MONOHYDRATE) 40 MGMarketed
02499452SANDOZ DOXYCYCLINESANDOZ CANADA INCORPORATEDCapsule (Immediate- And Delayed-Release)DOXYCYCLINE (DOXYCYCLINE MONOHYDRATE) 40 MGCancelled Pre Market

Notices of Compliance

NOCDateSubmissionReason
256332021-04-09New Drug Submission (NDS)LICENSING AGREEMENT BETWEEN TWO COMPANIES
Request a quote for APO-DOXYCYCLINE MR

How to read a Canadian DIN record